Menu
Home >> Important Document

Important Document

Important Document

Title Details
O.M. dated 02.05.2022 to Central Procurement Agencies to exercise due diligence on the claims of the local manufacturers while proceeding for the procurement
Seeking comments/views/ suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg
Guidelines on Pharmaceutical Innovation & Entrepreneurship
FAQs on the Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme 'Strengthening of Pharmaceuticals Industry' (SPI)
Extension of timeline to submit proposal: Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme Strengthening of Pharmaceuticals Industry (SPI)
Approval accorded to the States under the scheme 'Promotion of Medical Devices Park'
Awards to the leading Pharma and Medical Devices Industry playersIndia Pharma 2022 & India Medical Devices 2022-Extension of Date for invitation of Applications -reg
Annual Report 2021-22
Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli
Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022
Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg.
Portal for India Pharma and India Medical Device Awards
Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022
Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI)
Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022.
Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022
Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg.
List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021)
Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg.
Hiring of Technical Consultant for Pharmaceuticals and Medical Devices.
Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country
List of approved applicants under PLI Scheme for Medical Devices
Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021
Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals
List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India
Inviting details of local manufacturers of specific medical devices/equipments
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC).
Corrigendum under PLI scheme for Pharmaceuticals
Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract.
Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.
Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices
Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013.
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg
Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
Annual Report 2020-21
Observing the 7th International Yoga Day, 2021.

Pages